| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Biolife Solutions, Inc.'s insiders have reduced their positions by a net 1,200,000 shares worth roughly $28.1M.
Classified under Health Care Equipment & Supplies (Health Care sector), BLFS's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 4.76M | $164.88M | - | |
| CEO | 733.7K | $25.43M | - | |
| VP | 388.5K | $13.46M | - | |
| CFO | 213.2K | $7.39M | - | |
| Other | 162.6K | $5.64M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 12, 2024 | Foster Karen A.67 | Chief Quality And Operations | Sell | 66 | $26.34 | $1,738.44 | - | -2.2% | -2.2% | |
| Nov 12, 2024 | Mathew Aby J.68 | EVP &Chief Scientific Officer | Sell | 123 | $26.34 | $3,239.82 | - | -2.2% | -2.2% | |
| Nov 12, 2024 | Wichterman Troy60 | Chief Financial Officer | Sell | 147 | $26.19 | $3,849.93 | -0.1% | -2.2% | -2.2% | |
| Oct 31, 2024 | De Greef Roderick74 | President And CEO | Sell | 46,896 | $23.43 | $1,098,773.28 | -10.2% | +20.9% | +19.1% | |
| Oct 30, 2024 | Aebersold Sarah60 | Chief Human Resources Officer | Sell | 203 | $23.15 | $4,699.45 | -0.3% | +18.4% | +11.8% | |
| Oct 30, 2024 | Berard Todd67 | Chief Marketing Officer | Sell | 311 | $23.15 | $7,199.65 | -0.3% | +18.4% | +11.8% | |
| Oct 30, 2024 | Foster Karen A.67 | Chief Quality And Operations | Sell | 277 | $23.15 | $6,412.55 | -0.2% | +18.4% | +11.8% | |
| Oct 30, 2024 | Mathew Aby J.68 | EVP &Chief Scientific Officer | Sell | 547 | $23.15 | $12,663.05 | -0.2% | +18.4% | +11.8% | |
| Oct 30, 2024 | Wichterman Troy60 | Chief Financial Officer | Sell | 894 | $23.15 | $20,696.10 | -0.7% | +18.4% | +11.8% | |
| Oct 16, 2024 | Mathew Aby J.68 | EVP &Chief Scientific Officer | Sale+OE | 20,000 | $23.23 | $464,500.00 | -3.1% | +14.5% | +20.8% |